Last reviewed · How we verify
Felodipine sustained-release tablet
Felodipine sustained-release tablet is a Small molecule drug developed by Lee's Pharmaceutical Limited. It is currently FDA-approved.
Felodipine sustained-release tablet is used to treat hypertension and is classified as a mineralocorticoid receptor antagonist. It belongs to the class of small molecule antagonists.
At a glance
| Generic name | Felodipine sustained-release tablet |
|---|---|
| Sponsor | Lee's Pharmaceutical Limited |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study (PHASE1)
- The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients. (NA)
- Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension (PHASE4)
- Combined Antihypertensive Therapy and Sexual Dysfunction (PHASE4)
- Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Felodipine sustained-release tablet CI brief — competitive landscape report
- Felodipine sustained-release tablet updates RSS · CI watch RSS
- Lee's Pharmaceutical Limited portfolio CI
Frequently asked questions about Felodipine sustained-release tablet
What is Felodipine sustained-release tablet?
Who makes Felodipine sustained-release tablet?
What development phase is Felodipine sustained-release tablet in?
Related
- Manufacturer: Lee's Pharmaceutical Limited — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing